1. Acknowledgement to Referees

   Acknowledgement to Referees 30 October 2023 Pages: 1021 - 1026

2. The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review

   • Niloufar Pouyan
   • Farnaz Younesi Sisi
   • Jonathan D. Morrow

   Systematic Review Open access 24 November 2023 Pages: 1027 - 1063

   

3. Context is a Critical for Psychoactive Drug Effects

   • Kyle T. Greenway

   Commentary 24 November 2023 Pages: 1065 - 1068

4. Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study

   • Valeria Caponnetto
   • Antonio Russo
   • The Italian Headache Registry (RICe) Study Group

   Original Research Article Open access 24 November 2023 Pages: 1069 - 1080

   

5. Effects of Single and Multiple Ascending Doses of BI 1358894 in Healthy Male Volunteers on Safety, Tolerability and Pharmacokinetics: Two Phase I Partially Randomised Studies

   • René Fuertig
   • Markus Goettel
   • Vikas Sharma

   Original Research Article Open access 29 November 2023 Pages: 1081 - 1097

   

6. Effect of BI 1358894 on Cholecystokinin-Tetrapeptide (CCK-4)-Induced Anxiety, Panic Symptoms, and Stress Biomarkers: A Phase I Randomized Trial in Healthy Males

   • Markus Goettel
   • Rene Fuertig
   • Johan den Boer

   Original Research Article Open access 29 November 2023 Pages: 1099 - 1109

   

7. Levetiracetam Interaction with Direct Oral Anticoagulants: A Pharmacovigilance Study

   • Mohammed Abou Kaoud
   • Ran Nissan
   • Elad Maor

   Original Research Article 22 November 2023 Pages: 1111 - 1121